211 related articles for article (PubMed ID: 16621879)
1. Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Heart; 2006 Oct; 92(10):1434-40. PubMed ID: 16621879
[TBL] [Abstract][Full Text] [Related]
2. Comparative effects of valsartan and enalapril on cardiac sympathetic nerve activity and plasma brain natriuretic peptide in patients with congestive heart failure.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Heart; 2006 May; 92(5):625-30. PubMed ID: 16159967
[TBL] [Abstract][Full Text] [Related]
3. Effects of perindopril on cardiac sympathetic nerve activity in patients with congestive heart failure: comparison with enalapril.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur J Nucl Med Mol Imaging; 2005 Aug; 32(8):964-71. PubMed ID: 15803314
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
Kasama S; Toyama T; Sumino H; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
[TBL] [Abstract][Full Text] [Related]
5. Torasemide in chronic heart failure: results of the TORIC study.
Cosín J; Díez J;
Eur J Heart Fail; 2002 Aug; 4(4):507-13. PubMed ID: 12167392
[TBL] [Abstract][Full Text] [Related]
6. Addition of valsartan to an angiotensin-converting enzyme inhibitor improves cardiac sympathetic nerve activity and left ventricular function in patients with congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2003 Jun; 44(6):884-90. PubMed ID: 12791814
[TBL] [Abstract][Full Text] [Related]
7. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Am Coll Cardiol; 2005 Mar; 45(5):661-7. PubMed ID: 15734608
[TBL] [Abstract][Full Text] [Related]
8. [Effects of various diuretics on cardiac function in rats with heart failure].
Tanaka H; Watanabe K; Harima M; Thanikachalam PV; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
Yakugaku Zasshi; 2009 Jul; 129(7):871-9. PubMed ID: 19571523
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
Kasama S; Toyama T; Hatori T; Sumino H; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
Eur Heart J; 2007 Apr; 28(8):989-95. PubMed ID: 17409109
[TBL] [Abstract][Full Text] [Related]
10. Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial).
Trippel TD; Van Linthout S; Westermann D; Lindhorst R; Sandek A; Ernst S; Bobenko A; Kasner M; Spillmann F; González A; López B; Ravassa S; Pieske B; Paulus WJ; Díez J; Edelmann F; Tschöpe C
Eur J Heart Fail; 2018 Mar; 20(3):460-470. PubMed ID: 28891228
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2002 Oct; 43(10):1279-85. PubMed ID: 12368364
[TBL] [Abstract][Full Text] [Related]
12. Effects of spironolactone on cardiac sympathetic nerve activity and left ventricular remodelling after reperfusion therapy in patients with first ST-segment elevation myocardial infarction.
Kasama S; Toyama T; Sumino H; Kumakura H; Takayama Y; Minami K; Ichikawa S; Matsumoto N; Sato Y; Kurabayashi M
Heart; 2011 May; 97(10):817-22. PubMed ID: 21378011
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of torasemide and furosemide in rats with heart failure.
Veeraveedu PT; Watanabe K; Ma M; Thandavarayan RA; Palaniyandi SS; Yamaguchi K; Suzuki K; Kodama M; Aizawa Y
Biochem Pharmacol; 2008 Feb; 75(3):649-59. PubMed ID: 18001696
[TBL] [Abstract][Full Text] [Related]
14. Effect of spironolactone on cardiac sympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
J Am Coll Cardiol; 2003 Feb; 41(4):574-81. PubMed ID: 12598068
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study.
Besche B; Blondel T; Guillot E; Garelli-Paar C; Oyama MA
J Vet Intern Med; 2020 Sep; 34(5):1746-1758. PubMed ID: 32767627
[TBL] [Abstract][Full Text] [Related]
16. Short-Term Efficacy and Safety of Torasemide and Furosemide in 366 Dogs with Degenerative Mitral Valve Disease: The TEST Study.
Chetboul V; Pouchelon JL; Menard J; Blanc J; Desquilbet L; Petit A; Rougier S; Lucats L; Woehrle F;
J Vet Intern Med; 2017 Nov; 31(6):1629-1642. PubMed ID: 28975664
[TBL] [Abstract][Full Text] [Related]
17. Healthcare costs of patients with heart failure treated with torasemide or furosemide.
Stroupe KT; Forthofer MM; Brater DC; Murray MD
Pharmacoeconomics; 2000 May; 17(5):429-40. PubMed ID: 10977385
[TBL] [Abstract][Full Text] [Related]
18. Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure.
Kasama S; Toyama T; Kumakura H; Takayama Y; Ishikawa T; Ichikawa S; Suzuki T; Kurabayashi M
J Nucl Med; 2004 Jul; 45(7):1108-13. PubMed ID: 15235055
[TBL] [Abstract][Full Text] [Related]
19. The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.
Balsam P; Ozierański K; Tymińska A; Główczyńska R; Peller M; Fojt A; Cacko A; Sieradzki B; Bakuła E; Markulis M; Kowalik R; Huczek Z; Filipiak KJ; Opolski G; Grabowski M
Trials; 2017 Jan; 18(1):36. PubMed ID: 28114980
[TBL] [Abstract][Full Text] [Related]
20. Effects of statin therapy on cardiac sympathetic nerve activity and left ventricular remodeling in patients with chronic heart failure: a propensity score-matched analysis.
Sano H; Kasama S; Fujimoto S; Toyama T; Takama N; Koitabashi N; Ichikawa S; Suzuki Y; Matsumoto N; Sato Y; Kurabayashi M
Medicine (Baltimore); 2014 Dec; 93(27):e214. PubMed ID: 25501081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]